These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10583184)

  • 1. Hypertrichosis due to porphyria cutanea tarda associated with blastic transformation of myelofibrosis.
    Au WY; Tam SC; Ho KM; Lam CW; Kwong YL
    Br J Dermatol; 1999 Nov; 141(5):932. PubMed ID: 10583184
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertrichosis as the presenting feature of porphyria cutanea tarda.
    Boffa MJ; Reed P; Weinkove C; Ead RD
    Clin Exp Dermatol; 1995 Jan; 20(1):62-4. PubMed ID: 7671402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Images in clinical medicine. Porphyria cutanea tarda and hypertrichosis.
    Kapoor R; Johnson RA
    N Engl J Med; 2013 Oct; 369(14):1356. PubMed ID: 24088095
    [No Abstract]   [Full Text] [Related]  

  • 4. Paraneoplastic porphyria cutanea tarda associated with cholangiocarcinoma: case report.
    Sökmen M; Demirsoy H; Ersoy O; Gökdemir G; Akbayir N; Karaca C; Ozdil K; Kesici B; Calişkan C; Yilmaz B
    Turk J Gastroenterol; 2007 Sep; 18(3):200-5. PubMed ID: 17891697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case for diagnosis: porphyria cutanea tarda].
    Cochelin N; Vaillant L; Fauvel C; Lorette G
    Ann Dermatol Venereol; 1994; 121(5):417-8. PubMed ID: 7702271
    [No Abstract]   [Full Text] [Related]  

  • 6. A woman with hypertrichosis.
    Mirfazaelian H; Sotoude H; Negahban S; Aledavood A; Daneshbod Y
    Br J Hosp Med (Lond); 2014 May; 75(5):293. PubMed ID: 25040278
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypertrichosis lanuginosa of unknown origin in the area of the face. Porphyria cutanea tarda].
    Schulz C; Moll I
    Hautarzt; 2002 Dec; 53(12):827-9. PubMed ID: 12539751
    [No Abstract]   [Full Text] [Related]  

  • 8. [Circumscribed hypertrichosis lanuginosa in acute myeloid leukemia].
    Bauer HI; Kaatz M; Elsner P
    Dtsch Med Wochenschr; 2001 Jul; 126(30):845-6. PubMed ID: 11512282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porphyria cutanea tarda and hematologic malignancy--a report of 4 cases.
    McKenna DB; Browne M; O'Donnell R; Murphy GM
    Photodermatol Photoimmunol Photomed; 1997 Aug; 13(4):143-6. PubMed ID: 9453083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porphyria cutanea tarda, hepatitis C, alcoholism, and hemochromatosis: a case report and review of the literature.
    Sams H; Kiripolsky MG; Bhat L; Stricklin GP
    Cutis; 2004 Mar; 73(3):188-90. PubMed ID: 15074347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sclerodermatous changes in porphyria cutanea tarda: six cases].
    Khayat R; Dupuy A; Pansé I; Bagot M; Cordoliani F
    Ann Dermatol Venereol; 2013 Oct; 140(10):589-97. PubMed ID: 24090888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Between a rock and a hard place: management of systemic lupus erythematosus and porphyria cutanea tarda.
    Nyckowski T; Grammenos A; Vinokurov A; Nathoo R
    J Dermatolog Treat; 2022 Aug; 33(5):2689-2691. PubMed ID: 35362354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexistence of a systemic lupus erythematosus and porphyria cutanea tarda: case successfully improved by avoidance of sun exposure.
    Murata J; Shimizu T; Tateishi Y; Abe R; Shimizu H
    Int J Dermatol; 2006 Apr; 45(4):435-7. PubMed ID: 16650173
    [No Abstract]   [Full Text] [Related]  

  • 14. The prevalence of hepatitis C in patients with porphyria cutanea tarda in Stockholm, Sweden.
    Linde Y; Harper P; Floderus Y; Ros AM
    Acta Derm Venereol; 2005; 85(2):164-6. PubMed ID: 15823914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is porphyria cutanea tarda a paraneoplastic disorder?
    Poh-Fitzpatrick MB
    Clin Dermatol; 1993; 11(1):119-24. PubMed ID: 8101759
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of porphyria cutanea tarda in association with idiopathic myelofibrosis and CREST syndrome.
    Lee SC; Yun SJ; Lee JB; Lee SS; Won YH
    Br J Dermatol; 2001 Jan; 144(1):182-5. PubMed ID: 11167703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porphyria
    Serrano-Ordóñez A; Godoy-Díaz DJ; Lova-Navarro M
    Sultan Qaboos Univ Med J; 2023 May; 23(2):274-275. PubMed ID: 37377838
    [No Abstract]   [Full Text] [Related]  

  • 18. Generalized morphoea secondary to porphyria cutanea tarda.
    Stevens HP; Ostlere LS; Black CM; Rustin MH
    Br J Dermatol; 1993 Oct; 129(4):455-7. PubMed ID: 8105868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between porphyria cutanea tarda and beta-thalassemia major.
    Barbieri L; Macrì A; Lupia Palmieri G; Aurizi C; Biolcati G
    Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):36-9. PubMed ID: 19656449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of hepatitis C virus type 1b in Italian patients with Porphyria cutanea tarda.
    Sampietro M; Fracanzani AL; Corbetta N; Amato M; Mattioli M; Molteni V; Fiorelli G; Fargion S
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):543-7. PubMed ID: 9513830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.